NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

Australia flag Australia · Delayed Price · Currency is AUD
0.0710
-0.0040 (-5.33%)
At close: Mar 27, 2026
Market Cap23.61M +341.3%
Revenue (ttm)317.91K -85.6%
Net Income-3.18M
EPS-0.01
Shares Out332.58M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume125,949
Average Volume221,989
Open0.0710
Previous Close0.0750
Day's Range0.0690 - 0.0710
52-Week Range0.0340 - 0.2600
Beta1.08
RSI33.64
Earnings DateMay 26, 2026

About ASX:NSB

NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol NSB
Full Company Profile

Financial Performance

Financial Statements